Home » Roche Banks on New Drugs as Herceptin Faces Hurdle
Roche Banks on New Drugs as Herceptin Faces Hurdle
Swiss drugmaker Roche Holding AG expects results from 19 late-stage clinical trials over the next 18 months, providing a stream of products to offset a potential near-term threat to breast cancer drug Herceptin, its third biggest seller.
Reuters
Reuters
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May